Search results for "Depression"

showing 10 items of 1778 documents

Persistent dysgeusia post-halitosis treatment : how does it impact the patients? quality of life?

2019

Background The objective of this study was to evaluate the quality of life and the presence of anxiety and depression in patients with dysgeusia post halitosis treatment. Material and Methods Sixty patients were divided into three groups: Dysgeusia group (DG); Halitosis group (HG) and Control group (CG). The following instruments were used: Medical results study Short form health research of 36 items (SF-36), State-state anxiety inventory (STAI) and Self-report questionnaire-20 (SRQ-20). Results Of the 60 subjects studied, 85% were female and 15% were male. The evaluation of SF-36 indicated a statistically significant correlation between some domains for DG and showed low scores for Mental …

Malemedicine.medical_specialtyAnxietyVitalityDysgeusiaQuality of lifeInternal medicineSurveys and QuestionnairesmedicineHumansGeneral DentistryDepression (differential diagnoses)Oral Medicine and Pathologybusiness.industryDepressionResearchHalitosis:CIENCIAS MÉDICAS [UNESCO]Mental healthDysgeusiaBodily painOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeAnxietySurgeryFemalemedicine.symptomIt impactbusiness
researchProduct

Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up

2007

Abstract Objective Many studies have reported that cognitive ability may be predictive of the functional outcome for patients with schizophrenia. However, no study has prospectively examined these aspects in schizophrenia and bipolar disorders simultaneously. The present study attempted to analyze if neurocognition and clinical status predicts the real-life functioning for patients with schizophrenia or bipolar I disorder, using a longitudinal design. Method Forty-seven schizophrenic and 43 bipolar I outpatients were assessed twice with a neurocognitive battery (Executive Functions, Working Memory, Verbal Memory, Visual Memory, Visual-Motor Processing, Vigilance, Vocabulary and Motor Speed …

Malemedicine.medical_specialtyBipolar DisorderBipolar I disorderGlobal Assessment of FunctioningSeverity of Illness IndexDisability EvaluationYoung AdultPredictive Value of Testsmental disordersmedicineHumansProspective StudiesBipolar disorderPsychiatryDemographyWechsler ScalesNeuropsychologyHamilton Rating Scale for Depressionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologySchizophreniaFemaleVerbal memorymedicine.symptomCognition DisordersPsychologyNeurocognitiveManiaFollow-Up StudiesJournal of Affective Disorders
researchProduct

Burnout and depression among Spanish periodontology practitioners.

2009

Objectives: The objective of this study was to determine the prevalence of burnout syndrome and depression symptoms among periodontology practitioners, as well as the relationship with socio-demographic variables and work stress. Study Design: A total of 284 subjects, members of the Spanish Society of Periodontology (SEPA), were selected for this study. The Spanish version of the Maslach Burnout Inventory (MBI) and the Tetradimensional Estructural Questionnaire for Depression (TEC-DE) were sent by post to all participants. Descriptive statistics in addition to mean comparison and chi-square test were used for data analysis. Results: A response rate of 59.85% was obtained. From the total sam…

Malemedicine.medical_specialtyBurnoutDepersonalizationPrevalenceMedicineHumansEmotional exhaustionPsychiatryGeneral DentistryBurnout ProfessionalDepression (differential diagnoses)Response rate (survey)Descriptive statisticsbusiness.industryDepressionPeriodontology:CIENCIAS MÉDICAS [UNESCO]Test (assessment)Occupational DiseasesOtorhinolaryngologySpainUNESCO::CIENCIAS MÉDICASPeriodonticsSurgeryFemalemedicine.symptombusinessClinical psychologyMedicina oral, patologia oral y cirugia bucal
researchProduct

Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impair…

2019

Abstract Background Obesity is a low-grade inflammation condition that facilitates the development of numerous comorbidities and the dysregulation of brain homeostasis. Additionally, obesity also causes distinct behavioral alterations both in humans and rodents. Here, we investigated the effect of inducible genetic deletion of the cannabinoid type 1 receptor (CB1) in adipocytes (Ati-CB1-KO mice) on obesity-induced memory deficits, depressive-like behavior, neuroinflammation and adult neurogenesis. Methods Behavioral, mRNA expression and immunohistochemical studies were performed in Ati-CB1-KO mice and corresponding wild-type controls under standard and high-fat diet. Results Adipocyte-speci…

Malemedicine.medical_specialtyCannabinoid receptorNeurogenesisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentInflammationDiet High-FatMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyNeural Stem CellsNeuritisReceptor Cannabinoid CB1AdipocyteInternal medicineAdipocytesmedicineAnimalsBiological PsychiatryNeuroinflammationMice KnockoutMemory DisordersBehavior AnimalDepressionEndocrine and Autonomic Systemsbusiness.industryNeurogenesisBrain030227 psychiatryAdult Stem CellsPsychiatry and Mental healthEndocrinologynervous systemchemistryGliosisOrgan SpecificityCannabinoidmedicine.symptombusinessGene Deletion030217 neurology & neurosurgeryHomeostasisPsychoneuroendocrinology
researchProduct

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice.

2007

Hypothalamic-pituitary-adrenocortical (HPA) axis hyperactivity is associated with major depressive disorders, and treatment with classical antidepressants ameliorates not only psychopathological symptoms, but also the dysregulation of the HPA axis. Here, we further elucidated the role of impaired cannabinoid type 1 receptor (CB1) signaling for neuroendocrine and behavioral stress coping in the mouse forced swim test (FST). We demonstrate that the genetic inactivation of CB1 is accompanied by increased plasma corticosterone levels both under basal conditions and at different time points following exposure to the FST. The latter effect could be mimicked in C57BL/6N mice by acute, subchronic, …

Malemedicine.medical_specialtyCannabinoid receptorTime FactorsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAntidepressive Agents TricyclicStatistics NonparametricArticlechemistry.chemical_compoundMiceEndocrinologyRimonabantPiperidinesReceptor Cannabinoid CB1CorticosteroneDesipramineInternal medicineCannabinoid receptor type 1Adaptation PsychologicalmedicineAnimalsBiological PsychiatrySwimmingMice KnockoutAnalysis of VarianceEndocrine and Autonomic SystemsDepressionDesipramineMice Inbred C57BLPsychiatry and Mental healthDisease Models AnimalEndocrinologychemistrynervous systemPyrazoleslipids (amino acids peptides and proteins)FemaleCannabinoidRimonabantPsychologyCorticosteronehuman activitiesGlucocorticoidStress Psychologicalmedicine.drugBehavioural despair testSignal TransductionPsychoneuroendocrinology
researchProduct

The role of temperament and character in the outcome of depressive mood in eating disorders.

2014

Abstract Objectives The aims were to see which temperament and character dimensions were associated with depression, mainly with its outcome at two-year follow up in eating disorders (EDs). Methods Participants (N = 151) were 44 Anorexia nervosa (AN), 55 Bulimia nervosa (BN) and 52 Eating disorders not otherwise specified (EDNOS) patients. The Beck Depression Inventory (BDI), State and Trait Anxiety Inventory (STAI), Rosenberg Self Esteem Questionnaire (RSE), Eating Disorder Inventory (EDI-2) and Temperament and Character Inventory (TCI) were administered. Results Depression at the beginning (t0) was severe in 22% of the cases. Harm Avoidance and Novelty Seeking had an effect on depressed m…

Malemedicine.medical_specialtyCharacterAnorexia Nervosalcsh:RC435-571media_common.quotation_subjectbehavioral disciplines and activitiesBody Mass IndexYoung Adultlcsh:Psychiatrymental disordersmedicineHumansProspective StudiesPsychiatryBulimia NervosaTemperamentmedia_commonDepressive DisorderBulimia nervosaNovelty seekingBeck Depression Inventorymedicine.diseaseEating Disorder InventoryPsychiatry and Mental healthClinical PsychologyEating disordersHarm avoidanceTemperament and Character InventoryTemperamentFemalePsychologyClinical psychologyComprehensive psychiatry
researchProduct

Sensitivity, specificity and predictive value of the echocardiography and troponin-T test combination in patients with non-ST elevation acute coronar…

2004

Introduction: Patients with a negative troponin (TnT) result showed 1.4% mortality during a mean follow-up of 9–10 weeks. Mortality was greater in patients with an evidence of ischemic ECG changes and a negative TnT test (1.6–4.4%). Few studies have examined the efficacy of echocardiography (2DE) in patients with chest pain. The purpose of the present study was to determine the clinical utility, sensitivity and specificity of the combination of TnT levels and 2DE in patients presenting with chest pain, ST-depression, T-wave negative and no diagnostic ECG. Methods: 280 consecutive patients with chest pain and presence of ST depression, T-wave inversion, and non-diagnostic ECG, acceptable 2DE…

Malemedicine.medical_specialtyChest PainCoronary DiseaseChest painSensitivity and SpecificityTroponin TPredictive Value of TestsInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingST depressionChi-Square Distributionbiologymedicine.diagnostic_testTroponin Tbusiness.industryST elevationMiddle Agedmusculoskeletal systemTroponinEchocardiographyPredictive value of testsAngiographyAcute Diseasebiology.proteinCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessChi-squared distributionFollow-Up StudiesThe international journal of cardiovascular imaging
researchProduct

A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin.

2007

Patients with non-ST-elevation chest pain constitute a heterogeneous population. Our aim is to compare the outcome of patients with chest pain, non-ST-segment deviation, and normal troponin, categorized using a risk score, with that of patients with ST depression or troponin increase. A total of 1,449 patients with non-ST-elevation chest pain were evaluated. A validated risk score (using pain characteristics and risk factors) was applied to patients without ST depression or troponin increase. Accordingly, 4 risk categories were defined: group 1, no troponin increase, no ST depression, and risk score3 points (n = 633); group 2, no troponin increase, no ST depression, but risk scoreor = 3 poi…

Malemedicine.medical_specialtyChest painSeverity of Illness IndexAngina PectorisRisk categoryRisk FactorsInternal medicinemedicineMyocardial RevascularizationST segmentHumansAgedST depressionFramingham Risk Scorebiologybusiness.industryMiddle AgedPrognosisTroponinSurvival AnalysisTroponinHeterogeneous populationTreatment OutcomeSpainbiology.proteinCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalFollow-Up StudiesThe American journal of cardiology
researchProduct

Arrhythmias and inhibition of noradrenaline uptake caused by tricyclic antidepressants and chlorpromazine on the isolated perfused rabbit heart

1975

1. Isolated rabbit hearts were perfused with a modified Tyrode solution containing noradrenaline in concentrations increasing stepwise from 5.9 nM to 5.9 μM at 5 min intervals. This dose regime was applied twice before and once 20 min after starting perfusion with one of 9 tricyclic drugs. Ventricular rate and right atrial and ventricular tensions were recorded using the transverse method. 2. Infusions of noradrenaline evoked ventricular arrhythmias in hearts perfused with amitriptyline 4.8 μM, chlorpromazine 5.0 μM, desipramine 5.0 μM, dibenzepine 34.7 μM, doxepin 4.7 μM, imipramine 4.7 μM, noxiptiline 9.1 μM and opipramole 9.2 μM. The incidence of arrhythmias increased with the concentrat…

Malemedicine.medical_specialtyChlorpromazinePropranololAntidepressive Agents TricyclicIn Vitro TechniquesPharmacologyImipramineNorepinephrineCocaineCoronary CirculationDesipramineInternal medicinemedicineAnimalsAmitriptylineChlorpromazinePharmacologychemistry.chemical_classificationChemistryMyocardiumArrhythmias CardiacGeneral MedicineDoxepinPropranololPerfusionEndocrinologyDepression ChemicalIprindoleFemaleRabbitsmedicine.drugTricyclicNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

2020

Currently, chronic obstructive pulmonary disease (COPD) represents the fourth cause of death worldwide with significant economic burden. Comorbidities increase in number and severity with age and are identified as important determinants that influence the prognosis. In this observational study, we retrospectively analyzed data collected from the RePoSI register. We aimed to investigate comorbidities and outcomes in a cohort of hospitalized elderly patients with the clinical diagnosis of COPD. Socio-demographic, clinical characteristics and laboratory findings were considered. The association between variables and in-hospital, 3-month and 1-year follow-up were analyzed. Among 4696 in-patient…

Malemedicine.medical_specialtyChronic ObstructiveCirrhosisSocio-culturaleComorbidity030204 cardiovascular system & hematologycomorbiditieselderlyPulmonary Disease03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicinemedicine80 and overCOPDHumans030212 general & internal medicineLS4_4RegistriesHospital MortalityCOPD comorbidities elderly internal medicine in-hospital mortality.Depression (differential diagnoses)Cause of deathAgedRetrospective Studies1-year mortality; 3-month mortality; COPD; comorbidities; elderly; internal medicine; in-hospital mortalityAged 80 and overCOPDbusiness.industry1-year mortality; 3-month mortality; COPD comorbidities elderly internal medicine in-hospital mortalitymedicine.diseaseIm - Original1-year mortality; 3-month mortality; COPD comorbidities elderly internal medicine in-hospital mortality; Aged; Aged 80 and over; Comorbidity; Female; Humans; Internal Medicine; Male; Pulmonary Disease Chronic Obstructive; Registries; Retrospective Studies; Hospital Mortalityinternal medicineClinical diagnosisCohortEmergency Medicine1-year mortality3-month mortalityCOPD comorbidities elderly internal medicine in-hospital mortality1-year mortality 3-month mortality COPD comorbidities elderly internal medicine in-hospital mortality.Observational studyFemalebusiness1 year mortalityin-hospital mortality
researchProduct